Ignite Creation Date:
2025-12-25 @ 3:23 AM
Ignite Modification Date:
2026-01-16 @ 12:34 AM
Study NCT ID:
NCT04870905
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-03-06
First Post:
2021-05-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tisleilizumab (PD-1 Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma
Sponsor:
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Nasopharyngeal Neoplasms | View |
Keywords: